Arakawa Reijiro, Yokoyama Shinji
Biochemistry, Cell Biology, and Metabolism, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.
J Biol Chem. 2002 Jun 21;277(25):22426-9. doi: 10.1074/jbc.M202996200. Epub 2002 Apr 11.
ATP-binding cassette transporter (ABC) A1 was increased by apolipoprotein A-I without an increase of its message in THP-1 cells. The pulse label study demonstrated that apoA-I retarded degradation of ABCA1. Similar changes were demonstrated by apoA-II, but the effect of high density lipoprotein was almost negligible on the basis of equivalent protein concentration. Thiol protease inhibitors (leupeptin and N-acetyl-Leu-Leu-norleucinal (ALLN)) increased ABCA1 and slowed its decay in the cells, whereas none of the proteosome-specific inhibitor lactacystin, other protease inhibitors, or the lysosomal inhibitor NH(4)Cl showed such effects. The effects of apoA-I and ALLN were additive for the increase of ABCA1, and the apoA-I-mediated cellular lipid release was enhanced by ALLN. The data suggest that ABCA1 is rapidly degraded by a thiol protease(s) in the cells unless helical apolipoproteins in their lipid-free form stabilize ABCA1 by protecting it from protease-mediated degradation.
在THP-1细胞中,载脂蛋白A-I可增加ATP结合盒转运蛋白(ABC)A1的水平,但其信使RNA水平并未升高。脉冲标记研究表明,载脂蛋白A-I可延缓ABCA1的降解。载脂蛋白A-II也表现出类似的变化,但基于相同的蛋白质浓度,高密度脂蛋白的作用几乎可以忽略不计。巯基蛋白酶抑制剂(亮抑酶肽和N-乙酰亮氨酰-亮氨酰-正亮氨酸(ALLN))可增加细胞内ABCA1的水平并减缓其降解,而蛋白酶体特异性抑制剂乳胞素、其他蛋白酶抑制剂或溶酶体抑制剂NH₄Cl均未表现出此类作用。载脂蛋白A-I和ALLN对ABCA1增加的作用具有相加性,且ALLN可增强载脂蛋白A-I介导的细胞脂质释放。数据表明,除非无脂形式的螺旋载脂蛋白通过保护ABCA1免受蛋白酶介导的降解来使其稳定,否则ABCA1在细胞内会被巯基蛋白酶快速降解。